Abstract
In vivo effect of metronidazole on the active oxygen production by neutrophils in the peripheral blood of patients with urogenital chlamydial infection (9 females and 7 males) was studied with the use of luminol dependent chemiluminescence. Metronidazole was administered orally in a dose of 250 mg twice a day for 10 days. Blood for the specimens was collected prior to the treatment and on the next day of the treatment course completion. No effect on the spontaneous and zymozan or phorbol-12-myristate-13-acetate stimulated chemiluminescence was observed, although a significant increase in the chemiluminescence indices was stated in 3 females and 1 male. It was suggested that the changes in the individual values of the neutrophil chemiluminescence after the treatment were associated with the influence of metronidazole and/or its metabolites on the blood cells and with different activity of the host enzymes participating in the drug biotransformation.
| Original language | English |
|---|---|
| Pages (from-to) | 31-36 |
| Number of pages | 6 |
| Journal | Antibiotiki i Khimioterapiya |
| Volume | 43 |
| Issue number | 3 |
| Publication status | Published - 1998 |
| Externally published | Yes |
Fingerprint
Keywords
- Luminol dependent chemiluminescence of neutrophils
- Metronidazole
ASJC Scopus subject areas
- Microbiology
- Pharmacology
Cite this
Influence of Metronidazole on Luminol Dependent Chemiluminescence of Neutrophils in Whole Blood of Patients with Chlamydial Infection. / Shchepetkin, I. A.; Yuryev, S. Yu.
In: Antibiotiki i Khimioterapiya, Vol. 43, No. 3, 1998, p. 31-36.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Influence of Metronidazole on Luminol Dependent Chemiluminescence of Neutrophils in Whole Blood of Patients with Chlamydial Infection
AU - Shchepetkin, I. A.
AU - Yuryev, S. Yu
PY - 1998
Y1 - 1998
N2 - In vivo effect of metronidazole on the active oxygen production by neutrophils in the peripheral blood of patients with urogenital chlamydial infection (9 females and 7 males) was studied with the use of luminol dependent chemiluminescence. Metronidazole was administered orally in a dose of 250 mg twice a day for 10 days. Blood for the specimens was collected prior to the treatment and on the next day of the treatment course completion. No effect on the spontaneous and zymozan or phorbol-12-myristate-13-acetate stimulated chemiluminescence was observed, although a significant increase in the chemiluminescence indices was stated in 3 females and 1 male. It was suggested that the changes in the individual values of the neutrophil chemiluminescence after the treatment were associated with the influence of metronidazole and/or its metabolites on the blood cells and with different activity of the host enzymes participating in the drug biotransformation.
AB - In vivo effect of metronidazole on the active oxygen production by neutrophils in the peripheral blood of patients with urogenital chlamydial infection (9 females and 7 males) was studied with the use of luminol dependent chemiluminescence. Metronidazole was administered orally in a dose of 250 mg twice a day for 10 days. Blood for the specimens was collected prior to the treatment and on the next day of the treatment course completion. No effect on the spontaneous and zymozan or phorbol-12-myristate-13-acetate stimulated chemiluminescence was observed, although a significant increase in the chemiluminescence indices was stated in 3 females and 1 male. It was suggested that the changes in the individual values of the neutrophil chemiluminescence after the treatment were associated with the influence of metronidazole and/or its metabolites on the blood cells and with different activity of the host enzymes participating in the drug biotransformation.
KW - Luminol dependent chemiluminescence of neutrophils
KW - Metronidazole
UR - http://www.scopus.com/inward/record.url?scp=2542543748&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2542543748&partnerID=8YFLogxK
M3 - Article
C2 - 9606495
AN - SCOPUS:2542543748
VL - 43
SP - 31
EP - 36
JO - Antibiotiki i Khimioterapiya
JF - Antibiotiki i Khimioterapiya
SN - 0235-2990
IS - 3
ER -